Pfizer Inc Working Capital to Net Assets Ratio
Pfizer Inc working capital to net assets ratio. Pfizer Inc (PFIZ34) has a Working Capital to Net Assets ratio of 10.2% as of June 2026. Working capital of R$8.71 Billion (current assets of R$41.36 Billion minus current liabilities of R$32.65 Billion) is measured against net assets of R$85.49 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Pfizer Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Pfizer Inc (2014–2025)
Working capital to net assets ratio of Pfizer Inc from 2014 to 2025. This chart shows how Pfizer Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 10.2%, reflecting working capital of R$8.71 Billion against net assets of R$85.49 Billion BRL. See Pfizer Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Pfizer Inc Working Capital to Net Assets Ratio by Year (2014–2025)
Pfizer Inc working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Pfizer Inc from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see PFIZ34 total asset value.
| Year | WC/NA Ratio | Working Capital (BRL) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 6.8% | R$5.91 Billion | R$86.78 Billion | R$42.90 Billion | R$36.98 Billion | ▼ -1.5 pp |
| 2024 | 8.3% | R$7.36 Billion | R$88.50 Billion | R$50.36 Billion | R$42.99 Billion | ▲ +13.3 pp |
| 2023 | -5.0% | R$-4.46 Billion | R$89.29 Billion | R$43.33 Billion | R$47.79 Billion | ▼ -14.5 pp |
| 2022 | 9.5% | R$9.12 Billion | R$95.66 Billion | R$51.26 Billion | R$42.14 Billion | ▼ -12.5 pp |
| 2021 | 22.0% | R$17.02 Billion | R$77.20 Billion | R$59.69 Billion | R$42.67 Billion | ▲ +7.6 pp |
| 2020 | 14.5% | R$9.15 Billion | R$63.24 Billion | R$35.07 Billion | R$25.92 Billion | ▲ +21.6 pp |
| 2019 | -7.1% | R$-4.50 Billion | R$63.14 Billion | R$32.80 Billion | R$37.30 Billion | ▼ -35.6 pp |
| 2018 | 28.5% | R$18.07 Billion | R$63.41 Billion | R$49.93 Billion | R$31.86 Billion | ▲ +13.5 pp |
| 2017 | 15.0% | R$10.71 Billion | R$71.31 Billion | R$41.14 Billion | R$30.43 Billion | ▲ +1.9 pp |
| 2016 | 13.2% | R$7.83 Billion | R$59.54 Billion | R$38.95 Billion | R$31.11 Billion | ▼ -9.0 pp |
| 2015 | 22.2% | R$14.41 Billion | R$65.00 Billion | R$43.80 Billion | R$29.40 Billion | ▼ -25.3 pp |
| 2014 | 47.5% | R$34.01 Billion | R$71.62 Billion | R$55.59 Billion | R$21.59 Billion | — |